We have no immediate plans for merger: Amit Varma

Interview with Managing Partner, Quadria Capital Investment Advisors

Reghu Balakrishnan Mumbai
Last Updated : Mar 27 2013 | 10:28 PM IST
Till a week ago, Quadria Capital Investment Advisors was one among the hundreds of Asia-focused unknown private equity firms. Its recent acquisition of Milestone Religare Investment Advisors, a 50:50 joint venture between Milestone Capital and Religare, has catapulted it into the spotlight. Amit Varma, managing partner, had been involved with the Milestone Religare franchise since inception. He is also a critical care physician with two decades' practice in the US and India. He speaks to Reghu Balakrishnan on the plans of Milestone-Religare. Edited excerpts:

After buyout, what are the priorities?
The priority is to manage the current investments as the fund is now completely deployed.

We are looking at exits in the next 24 to 36 months.
We have to take stock and decide on potential future fund raises after a couple of months of stabilisation.

What are your plans?
We need to speak with all stakeholders - team and contributors - and then it will be decided. At this time, no changes are contemplated. Our current team has adequate size with four members, a good blend of seniors and juniors.

How are the portfolios and the exit plans?
Pretty much all investments are doing well, based on follow-on investments in the companies. CARE Ratings has gone for an initial public offering recently. Exits will be a mix of primary and secondary deals.

Any plans to raise new funds?
We will strategise and discuss this post-stabilisation over the next couple of months and look at the possibility of a domestic raise. We would like to stay core to healthcare, going forward.

What about Quadria's $300-million healthcare fundraising plans?
We are looking at an imminent first close and a final close in the second quarter of 2014. With regard to investments, there are four quadrants of interests - healthcare delivery, life sciences, medical technology and retail health. The investment bite size for us is $10-50 million. The geography for investments is South Asia and Southeast Asia, which does not include China.

Is there any plan to merge Milestone-Religare with Quadria?
At this time, the intention is to keep the platform separate, with independent professional teams. The Milestone-Religare team is in India and the Quadria Asia team is between Singapore and Delhi.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 27 2013 | 10:28 PM IST

Next Story